Targeted antigen delivery and activation of dendritic cells in vivo: Steps towards cost effective vaccines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeted antigen delivery and activation of dendritic cells in vivo: Steps towards cost effective vaccines

Published:2011-02 Issue:1 Volume:23 Page:12-20
ISSN:1044-5323
Container-title:Seminars in Immunology
language:en
Short-container-title:Seminars in Immunology

Author:

Tacken Paul J.,Figdor Carl G.

Funder

2004-3127

Dutch Cancer Society

The Netherlands Organization of Scientific Research (NWO)

TIL-foundation

NOTK

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference125 articles.

1. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting;Tacken;Nat Rev Immunol,2007

2. Enhanced antigen immunogenicity induced by bispecific antibodies;Snider;J Exp Med,1990

3. Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells;Young;Nat Immunol,2008

4. Antigen crosspresentation by human plasmacytoid dendritic cells;Hoeffel;Immunity,2007

5. Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I;Di Pucchio;Nat Immunol,2008

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bibliometric analysis of dendritic cell-based vaccines over the past 15 years;Human Vaccines & Immunotherapeutics;2024-08-19

2. Vaccine approaches to treat urothelial cancer;Human Vaccines & Immunotherapeutics;2024-07-23

3. Immunoprotection of FliBc chimeric fiber2 fusion proteins targeting dendritic cells against Fowl adenovirus serotype 4 infection;Poultry Science;2024-04

4. Combined use of TLR4 and TLR7/8 agonists to improve the efficacy of immune checkpoint inhibitors in “hot” tumor treatment and the establishment of long-term immune protection;2023-12-13

5. The Potential of Dendritic Cell Subsets in the Development of Personalized Immunotherapy for Cancer Treatment;Current Issues in Molecular Biology;2023-10-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3